Single-dose Study to Assess Pharmacokinetics of Solifenacin Succinate Suspension in Children and Adolescents
Status:
Completed
Trial end date:
2011-08-14
Target enrollment:
Participant gender:
Summary
This single-dose study will investigate how well solifenacin suspension is taken up, how long
it stays in the body and how well it will be tolerated in children and adolescents aged 5-17
years with symptoms of overactive bladder.